Evidence map›Paper›PMID 19644962›Full record

ArticleArthritis and rheumatism2009

European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus.

Sharon A Chung, Chao Tian, Kimberly E Taylor, Annette T Lee, Ward A Ortmann, Geoffrey Hom, Robert R Graham, Joanne Nititham, Jennifer A Kelly, Jean Morrisey and 14 more

Abstract read
In one paragraph

Article in Arthritis and rheumatism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Systemic lupus erythematosus diagnostics in the 'omics' era.International journal of clinical rheumatology · 2013
    Article
  10. Article
  11. Article
  12. Stronger bone correlates with African admixture in African-American women.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2011
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Sharon A ChungDivision of Rheumatology, University of California, San Francisco, CA 94143-0500, USA. sharon.chung@ucsf.edu
Chao Tian
Kimberly E Taylor
Annette T Lee
Ward A Ortmann
Geoffrey Hom
Robert R Graham
Joanne Nititham
Jennifer A Kelly
Jean Morrisey
Hui Wu
Hong Yin
Marta E Alarcón-Riquelme
Betty P Tsao
John B Harley
Patrick M Gaffney
Kathy L Moser
Susan Manzi
Michelle Petri
Peter K Gregersen
Carl D Langefeld
Timothy W Behrens
Michael F Seldin
Lindsey A Criswell

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
WITHIN SUBJ VARIABILITY IN MEASUREMENTS DRUG METABOL ENZYMES IN HLTY SUBJM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, ARTHUR S · 1985 to 2006
$29.2M
ZD1839 FOR MALIGNANT ASTROCYTOMA OR GLIOBLASTOMA AND MENINGIOMAM01RR000079 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$26.0M
THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CENTOLA, MICHAEL B · 2000 to 2009
$21.5M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARLEY, JOHN BARKER · 2002 to 2012
$12.7M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YELIN, EDWARD H · 2006 to 2016
$11.8M
Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
GENE MAPPING IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUSR01AR043274 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SIVILS, KATHY L. · 1996 to 2010
$6.5M
NCATS NIH HHS UL1 TR000005NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000056NCRR NIH HHS M01-RR000056NCRR NIH HHS M01 RR000079NCRR NIH HHS M01 RR-00052NCRR NIH HHS M01 RR-00079NCRR NIH HHS P20-RR-015577NCRR NIH HHS P20 RR020143NCRR NIH HHS P20-RR-020143NCRR NIH HHS UL1 RR024153NCRR NIH HHS UL1-RR-024153NIAID NIH HHS R01 AI063274NIAID NIH HHS R01-AI-063274NIAID NIH HHS R01 AI068759NIAID NIH HHS R01-AI-31584NIAID NIH HHS R01-AI-68759NIAID NIH HHS R37 AI024717NIAID NIH HHS R37-AI-24717NIAMS NIH HHS K24 AR002175NIAMS NIH HHS K24 AR002213NIAMS NIH HHS K24-AR-002213NIAMS NIH HHS K24-AR-02175NIAMS NIH HHS N01 AR062277NIAMS NIH HHS N01-AR-12253NIAMS NIH HHS N01-AR-62277NIAMS NIH HHS P01-AR-049084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P50-AR-48940NIAMS NIH HHS P60 AR053308NIAMS NIH HHS P60-AR-053308NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01-AR-042460NIAMS NIH HHS R01 AR043274NIAMS NIH HHS R01-AR-043274-13NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01-AR-043814NIAMS NIH HHS R01 AR046588NIAMS NIH HHS R01 AR050267NIAMS NIH HHS R01-AR-050267NIAMS NIH HHS R01 AR052125NIAMS NIH HHS R01-AR-052125NIAMS NIH HHS R01 AR052300NIAMS NIH HHS R01-AR-052300NIAMS NIH HHS R01-AR-46588NIAMS NIH HHS R37-AR-62277PHS HHS R01-043727
6 · The paper itself

Abstract

objectiveTo determine whether genetic substructure in European-derived populations is associated with specific manifestations of systemic lupus erythematosus (SLE), including mucocutaneous phenotypes, autoantibody production, and renal disease.

methodsSLE patients of European descent (n=1,754) from 8 case collections were genotyped for >1,400 ancestry informative markers that define a north-south gradient of European substructure. Using the Structure program, each SLE patient was characterized in terms of percent Northern (versus percent Southern) European ancestry based on these genetic markers. Nonparametric methods, including tests for trend, were used to identify associations between Northern European ancestry and specific SLE manifestations.

resultsIn multivariate analyses, increasing levels of Northern European ancestry were significantly associated with photosensitivity (Ptrend=0.0021, odds ratio for highest quartile of Northern European ancestry versus lowest quartile [ORhigh-low] 1.64, 95% confidence interval [95% CI] 1.13-2.35) and discoid rash (Ptrend=0.014, ORhigh-low 1.93, 95% CI 0.98-3.83). In contrast, increasing levels of Northern European ancestry had a protective effect against the production of anticardiolipin autoantibodies (Ptrend=1.6x10(-4), ORhigh-low 0.46, 95% CI 0.30-0.69) and anti-double-stranded DNA autoantibodies (Ptrend=0.017, ORhigh-low 0.67, 95% CI 0.46-0.96).

conclusionThis study demonstrates that specific SLE manifestations vary according to Northern versus Southern European ancestry. Thus, genetic ancestry may contribute to the clinical heterogeneity and variation in disease outcomes among SLE patients of European descent. Moreover, these results suggest that genetic studies of SLE subphenotypes will need to carefully address issues of population substructure based on genetic ancestry.

Indexed as

Genetic Predisposition to DiseaseAdultAntibodies, AnticardiolipinEuropeFemaleHumansLupus Erythematosus, CutaneousLupus Erythematosus, SystemicMalePhenotypePhotosensitivity DisordersWhite PeopleYoung AdultAntibodies, Anticardiolipin

Identifiers

PMID19644962
PMCPMC2739103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.